26 Participants Needed

DASH Diet for Heart Failure

(DASH-HF Trial)

Recruiting at 1 trial location
BW
FS
Overseen ByFrancene Steinberg, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Davis
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to refine the classification of the effectiveness of the DASH diet for outpatient heart failure (HF) management, using behavioral, clinical, and laboratory correlative science approaches.

Do I need to stop my current medications for the trial?

The trial does not specify if you need to stop your current medications, but it requires that your heart failure treatment is stable for at least 30 days before joining.

Is the DASH diet generally safe for humans?

The DASH diet is generally safe for most people and can be adopted alongside medication and other lifestyle changes. However, caution is advised for individuals with chronic kidney or liver disease, and those on certain medications, as modifications may be needed.12345

How is the DASH diet treatment different from other treatments for heart failure?

The DASH diet is unique because it focuses on a balanced eating plan that reduces blood pressure and LDL cholesterol, which may help manage heart failure. Unlike other treatments that often emphasize dietary restrictions, the DASH diet aims to meet nutritional needs and improve overall heart health.12567

What data supports the effectiveness of the DASH diet treatment for heart failure?

The DASH diet, known for lowering blood pressure, may help manage heart failure by improving heart health and reducing complications. Some studies suggest it could be beneficial for heart failure patients, although results have been mixed.15678

Who Is on the Research Team?

FS

Francene Steinberg, PhD

Principal Investigator

University of California, Davis

Are You a Good Fit for This Trial?

This trial is for heart failure patients who have been on a stable, optimized medical regimen for at least 30 days. It's not suitable for individuals with a BMI under 18.5, those experiencing severe weight loss due to illness (cardiac cachexia), end-stage kidney disease or dialysis, ongoing inflammation, uncontrolled heart rhythm problems or ischemia, or those who've had a heart transplant or have an implanted heart pump.

Inclusion Criteria

I have been diagnosed with heart failure.
My current treatment for my condition has been stable for at least 30 days.

Exclusion Criteria

Your body mass index (BMI) is below 18.5.
You have had a heart transplant or have a device to help your heart pump.
I have irregular heartbeats or heart issues not managed by medication.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive nutrition education and medical nutrition therapy counseling focusing on DASH diet implementation and adherence for heart failure management

6 months
4 visits (in-person) at 1, 2, 3, and 6 months

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments of dietary intake, blood pressure, and heart failure symptoms

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • DASH diet
Trial Overview The study is examining the effectiveness of the DASH diet—a dietary approach to stop hypertension—in managing outpatient heart failure. Researchers will use behavioral assessments and clinical tests to measure how well this diet works in improving patient health.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Dietary Intervention ArmExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Davis

Lead Sponsor

Trials
958
Recruited
4,816,000+

American College of Cardiology

Collaborator

Trials
18
Recruited
312,000+

Published Research Related to This Trial

Adherence to the DASH diet is linked to a lower risk of developing heart failure (HF) in a diverse population of adults aged 45 and older, with significant reductions in risk observed in those under 75 years old.
The study analyzed data from the REGARDS cohort, finding that individuals in higher DASH diet score quartiles had a reduced hazard ratio for incident HF, indicating that a healthier diet may help prevent heart failure.
The Dietary Approaches to Stop Hypertension (DASH) Diet Pattern and Incident Heart Failure.Goyal, P., Balkan, L., Ringel, JB., et al.[2023]
In a study of 36,019 women aged 48 to 83, those who closely followed the DASH diet had a 37% lower rate of heart failure (HF) over 7 years compared to those who did not, even after adjusting for various health and lifestyle factors.
The results suggest that adherence to the DASH diet is linked to a significant reduction in the risk of heart failure, indicating its potential as a preventive dietary approach for heart health.
Consistency with the DASH diet and incidence of heart failure.Levitan, EB., Wolk, A., Mittleman, MA.[2021]
Heart failure (HF) patients often face complex challenges due to deranged physiology and malnutrition, making effective nutritional strategies crucial for their care.
The DASH (Dietary Approaches to Stop Hypertension) diet may be particularly beneficial for HF patients, as it aligns with the need for a dietary program that supports both nutritional needs and HF management goals.
A Review of the DASH Diet as an Optimal Dietary Plan for Symptomatic Heart Failure.Rifai, L., Silver, MA.[2019]

Citations

The Dietary Approaches to Stop Hypertension (DASH) Diet Pattern and Incident Heart Failure. [2023]
Consistency with the DASH diet and incidence of heart failure. [2021]
Adherence to the dietary approaches to stop hypertension diet and all-cause mortality in patients with a history of heart failure. [2022]
A Review of the DASH Diet as an Optimal Dietary Plan for Symptomatic Heart Failure. [2019]
Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization: design and rationale for the Geriatric OUt of hospital Randomized MEal Trial in Heart Failure (GOURMET-HF). [2018]
Rationale and design of the Optimal Macro-Nutrient Intake Heart Trial to Prevent Heart Disease (OMNI-Heart). [2017]
Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. [2021]
The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security